Purchase Order 75N93026P00012
- Not listed
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $12,332.71 firm fixed-price purchase order is for the delivery of Qiagen's products and services, which likely include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $17,090.82 firm fixed-price contract was awarded to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The contract is a Blanket Purchase Agreement (BPA) call, indicating it is part of a larger indefinite delivery vehicle. Qiagen, LLC is...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $4,094.11 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. This award does not have a set-aside designation. The award supports Qiagen's provision of products and services to NIAID, such as DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and bioinformatics...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $33,646.00 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for a 1-year license to access the Human Gene Mutation Database, which provides data on approximately 200,000 human genomic mutations. This data supports NIAID's efforts to build a custom bioinformatics...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., for $32,634.00. The contract provides one-year access to the Human Gene Mutation Database for clinical use at the NIH Clinical Center to support a custom bioinformatics pipeline for analyzing genomic data from patients enrolled in NIAID clinical protocols. This sole-source...
- The National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,896.00 firm fixed-price purchase order to Qiagen, LLC for HGMD DOWNLOAD, RESEARCH USE, LAB services. The contract has an ultimate completion date of November 30, 2024 and was awarded on December 1, 2023. This award does not utilize a set-aside designation. Qiagen, LLC is a division of the international biotechnology company Qiagen N.V. and has provided various...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The $7,820.97 award supports the provision of Qiagen's products and services, which include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, bioinformatics software, and precision medicine analysis tools. Qiagen has a long history...
- This federal contract award to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V., is for maintenance services. The $4,348.00 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract does not have a set-aside designation. Qiagen is a leading provider of molecular diagnostic products and services to federal agencies, supporting critical...
- The federal contract award HHSN272201200151P was issued to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The $3,172.23 firm-fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, and does not have a set-aside designation. Qiagen is a leading provider of sample and assay technologies for molecular diagnostics, applied testing, and academic research. Under...
- Qiagen, LLC received a $29,166.25 firm fixed-price purchase order from the NIH Clinical Center, awarded on January 1, 2026, with a completion date of December 31, 2026. This contract carries no set-aside designation, allowing Qiagen to compete in the open federal marketplace. The award is for delivery to Germantown, Maryland, where Qiagen maintains its headquarters operations. As a foreign-owned manufacturer specializing in molecular diagnostics, scientific equipment, and bioinformatics...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $66,514.95 firm fixed-price purchase order to Qiagen, LLC for clinical long read genomics services supporting the NIAID Centralized Sequencing Program, Human Genome Mutation Database (HGMD) initiative. The contract, effective from March 1, 2026 through February 28, 2027, will be performed at Qiagen's facility in Germantown, Maryland. This award was made without a small business set-aside designation, reflecting the specialized and proprietary nature of Qiagen's advanced genomic sequencing capabilities and the limited competitive sources available for such technical services. Qiagen, LLC is a foreign-owned molecular diagnostics and bioinformatics solutions provider headquartered in Germantown, Maryland, with an extensive federal contract portfolio spanning multiple agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Defense Health Agency, and Federal Bureau of Investigation. The company maintains substantial indefinite delivery contract vehicles and blanket purchase agreements valued in the tens of millions of dollars across the federal government, positioning it as a critical supplier for genomic analysis, DNA/RNA extraction technologies, and precision medicine applications that support biomedical research and public health surveillance initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $66.5k | 2/26/26 |